Evidence map›Paper›PMID 21303506›Full record

ArticleBMC biochemistry2011

Protein kinase A type I activates a CRE-element more efficiently than protein kinase A type II regardless of C subunit isoform.

Øystein Stakkestad, Anja C V Larsen, Anne-Katrine Kvissel, Sissel Eikvar, Sigurd Ørstavik, Bjørn S Skålhegg

Open access · hybridAbstract readComparative Study
In one paragraph

Article in BMC biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Øystein StakkestadDepartment of Nutrition, Institute for Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, P,O, Box 1046 Blindern, N- 0316 OSLO, Norway.
Anja C V Larsen
Anne-Katrine Kvissel
Sissel Eikvar
Sigurd Ørstavik
Bjørn S Skålhegg
University of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProtein kinase A type I (PKAI) and PKAII are expressed in most of the eukaryotic cells examined. PKA is a major receptor for cAMP and specificity is achieved partly through tissue-dependent expression and subcellular localization of subunits with different biochemical properties. In addition posttranslational modifications help fine tune PKA activity, distribution and interaction in the cell. In spite of this the functional significance of two forms of PKA in one cell has not been fully determined. Here we have tested the ability of PKAI and PKAII formed by expression of the regulatory (R) subunits RIα or RIIα in conjunction with Cα1 or Cβ2 to activate a co-transfected luciferace reporter gene, controlled by the cyclic AMP responsive element-binding protein (CREB) in vivo.

resultsWe show that PKAI when expressed at equal levels as PKAII was significantly (p < 0.01) more efficient in inducing Cre-luciferace activity at saturating concentrations of cAMP. This result was obtained regardless of catalytic subunit identity.

conclusionWe suggest that differential effects of PKAI and PKAII in inducing Cre-luciferace activity depend on R and not C subunit identity.

Indexed as

Gene Expression RegulationResponse ElementsCyclic AMPCyclic AMP-Dependent Protein Kinase Type ICyclic AMP-Dependent Protein Kinase Type IICyclic AMP Response Element-Binding ProteinGenes, ReporterHEK293 CellsHumansLuciferasesProtein BindingProtein IsoformsCyclic AMPCyclic AMP-Dependent Protein Kinase Type ICyclic AMP-Dependent Protein Kinase Type IICyclic AMP Response Element-Binding ProteinLuciferasesProtein Isoforms

Identifiers

PMID21303506
PMCPMC3060122
OpenAlexW2077302972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.